Citation Impact
Citing Papers
Adverse metabolic and cardiovascular consequences of circadian misalignment
2009 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
The Metabolic Syndrome and Inflammation
2004
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Mechanisms of Thrombus Formation
2008 Standout
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
2006 Standout
Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis
1994
Bleeding with anticoagulation therapy – Who is at risk, and how best to identify such patients
2009
The Chronic Inflammatory Hypothesis for the Morbidity Associated with Morbid Obesity: Implications and Effects of Weight Loss
2004
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Contribution of platelets to tumour metastasis
2011 Standout
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Imaging the Glycosylation State of Cell Surface Glycoproteins by Two‐Photon Fluorescence Lifetime Imaging Microscopy
2013 StandoutNobel
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
2008 Standout
Is there a hypercoagulable phase during initiation of antithrombotic therapy with oral anticoagulants in patients with atrial fibrillation?
2003
Oral Anticoagulant Therapy
2012 Standout
The metabolic syndrome
2010 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 Patients
1992
Sex, Clinical Presentation, and Outcome in Patients with Acute Coronary Syndromes
1999
Emergency Hospitalizations for Adverse Drug Events in Older Americans
2011 Standout
Association between Anxiety and Factors of Coagulation and Fibrinolysis
2008
HLA-B*5701 Screening for Hypersensitivity to Abacavir
2008 Standout
Critical review of acylation-stimulating protein physiology in humans and rodents
2003
Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance
2000
Coordinated Transcription of Key Pathways in the Mouse by the Circadian Clock
2002 Standout
The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
1995 Standout
The role of fat cell derived peptides in age-related metabolic alterations
2001
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients
2008
The metabolic syndrome
2005 Standout
Obesity, haemostasis and the fibrinolytic system
2002
Prognostic value of the admission electrocardiogram in patients with unstable angina/non–ST-segment elevation myocardial infarction treated with very early revascularization
2004
The Antiphospholipid Syndrome
2002 Standout
Hemodynamic Shear Stress and Its Role in Atherosclerosis
1999 Standout
Effects of Dietary Composition on Energy Expenditure During Weight-Loss Maintenance
2012
Prevention of Venous Thromboembolism
2004 Standout
Characterization of the Novel P-Selectin Inhibitor PSI-697 [2-(4-Chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[h] Quinoline-4-carboxylic acid] in Vitro and in Rodent Models of Vascular Inflammation and Thrombosis
2007
Circadian Variation of Fibrinolytic Activity in Blood
1991
Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk
2004
Effect of ambient particulate matter exposure on hemostasis
2007
Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ
2004 StandoutNature
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
1991 Standout
Women do have an improved long-term outcome after non–ST-elevation acute coronary syndromes treated very early and predominantly with percutaneous coronary intervention
2002
Decreased Plasma Adiponectin Levels in Young Obese Males.
2003
The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI
2000 Standout
Obesity is associated with macrophage accumulation in adipose tissue
2003 Standout
Coagulation and Fibrinolysis during Laparoscopic Cholecystectomy
1999
Adipose Tissue as an Endocrine Organ
2004 Standout
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Health disorders of shift workers
2003
The pharmacogenetics of antiretroviral therapy
2006
Weight change and blood coagulability and fibrinolysis in healthy obese women
2001
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Carbamazepine for chronic neuropathic pain and fibromyalgia in adults
2014
Regulation of the endothelial cell urokinase-type plasminogen activator receptor. Evidence for cyclic AMP-dependent and protein kinase C-dependent pathways.
1993 StandoutNobel
Adipose Tissue, Inflammation, and Cardiovascular Disease
2005 Standout
Plasminogen Activators, Tissue Degradation, and Cancer
1985 Standout
Fluid Flow Stimulates Tissue Plasminogen Activator Secretion by Cultured Human Endothelial Cells
1989 Science
Multiplex Assay for Comprehensive Genotyping of Genes Involved in Drug Metabolism, Excretion, and Transport
2007
A Transgenic Model of Visceral Obesity and the Metabolic Syndrome
2001 StandoutScience
Targeting RGD Recognizing Integrins: Drug Development, Biomaterial Research, Tumor Imaging and Targeting
2006
Stromal Cells Are the Main Plasminogen Activator Inhibitor-1-Producing Cells in Human Fat
2002
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
Comprehensive Assessment of Metabolic Enzyme and Transporter Genes Using the Affymetrix ® Targeted Genotyping System
2007
Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.
1990 StandoutNobel
Putting polyphosphates to the test: evidence against platelet-induced activation of factor XII
2013 StandoutNobel
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Particulate Matter Air Pollution and Cardiovascular Disease
2010 Standout
Obesity is associated with macrophage accumulation in adipose tissue
2003 Standout
Low-Molecular-Weight Heparins
1997 Standout
The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation
2001
Ir-CPI, a coagulation contact phase inhibitor from the tick Ixodes ricinus, inhibits thrombus formation without impairing hemostasis
2009
The Halogen Bond
2016 Standout
Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium.
1988 Standout
Design, Structure−Activity Relationships, X-ray Crystal Structure, and Energetic Contributions of a Critical P1 Pharmacophore: 3-Chloroindole-7-yl-Based Factor Xa Inhibitors
2008
Tumors: Wounds That Do Not Heal
1986 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Flow-mediated endothelial mechanotransduction
1995 Standout
Works of Mojca Stegnar being referenced
Influence of CYP2C9 polymorphisms, demographic factors and concomitant drug therapy on warfarin metabolism and maintenance dose
2005
Fibrinolytic response to venous occlusion in healthy subjects: Relationship to age, gender, body weight, blood lipids and insulin
1993
Poor fibrinolytic response to venous occlusion by different criteria in patients with deep vein thrombosis
1991
D-dimer, other markers of haemostasis activation and soluble adhesion molecules in patients with different clinical probabilities of deep vein thrombosis
2002
Design and synthesis of novel platelet fibrinogen receptor antagonists with 2H-1,4-benzoxazine-3(4H)-one scaffold. A systematic study
2004
Markers of hemostatic system activation during treatment of deep vein thrombosis with subcutaneous unfractionated or low-molecular weight heparin
2002
Evaluation of two experimental venous thrombosis models in the rat
2004
Do Haemostasis Activation Markers that Predict Cardiovascular Disease Exist?
2003
Prevalence of antiphospholipid antibodies in deep vein thrombosis and their relationship to blood coagulation and fibrinolysis
1991
Do baseline serum leptin levels predict weight regain after dieting in obese women?
2001
The influence of co-treatment with carbamazepine, amiodarone and statins on warfarin metabolism and maintenance dose
2006
PHYSICAL ACTIVITY RELEASES TISSUE PLASMINOGEN ACTIVATOR FROM EXERCISING PARTS OF BODY
1987
Plasminogen activator inhibitor I response to a carbohydrate meal in obese subjects
1990
14 Reduced diurnal rhythm of fibrinolytic activity in patients with pace-maker
1988
Isolation and Characterization of Plasminogen Activator from Pig Leucocytes
1974
The influence of sequence variations in factor VII, γ-glutamyl carboxylase and vitamin K epoxide reductase complex genes on warfarin dose requirement
2006
Shift work and circadian rhythm of blood fibrinolytic parameters
1990
Influence of Moderate and Strenuous Daily Physical Activity on Fibrinolytic Activity of Blood: Possibility of Plasminogen Activator Stores Depletion
1979
Impact of Adipose Tissue on Plasma Plasminogen Activator Inhibitor-1 in Dieting Obese Women
1999
A novel sequence variant in exon 7 of CYP2C9 gene (CYP2C9*24) ina patient on warfarin therapy
2006